000 01399 a2200385 4500
005 20250517231827.0
264 0 _c20190722
008 201907s 0 0 eng d
022 _a1750-7448
024 7 _a10.2217/imt-2017-0183
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAguiar, Pedro
245 0 0 _aCost-effectiveness and budget impact of lung cancer immunotherapy in South America: strategies to improve access.
_h[electronic resource]
260 _bImmunotherapy
_c08 2018
300 _a887-897 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents, Immunological
_xeconomics
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aCost-Benefit Analysis
650 0 4 _aEconomics, Pharmaceutical
650 0 4 _aHealth Services Accessibility
_xeconomics
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xeconomics
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aSouth America
700 1 _aGiglio, Auro Del
700 1 _aPerry, Luke Alastair
700 1 _aPenny-Dimri, Jahan
700 1 _aBabiker, Hani
700 1 _aTadokoro, Hakaru
700 1 _aLopes, Gilberto
700 1 _aDe Mello, Ramon Andrade
773 0 _tImmunotherapy
_gvol. 10
_gno. 10
_gp. 887-897
856 4 0 _uhttps://doi.org/10.2217/imt-2017-0183
_zAvailable from publisher's website
999 _c28696793
_d28696793